Repositioning Candidate Details
| Candidate ID: | R0529 |
| Source ID: | DB01563 |
| Source Type: | approved; illicit; investigational; vet_approved |
| Compound Type: | small molecule |
| Compound Name: | Chloral hydrate |
| Synonyms: | 1,1,1-trichloro-2,2-dihydroxyethane; 1,1,1-trichloro-2,2-ethanediol; 2,2,2-trichloro-1,1-ethanediol; Chloral hydrate; chloral monohydrate; trichloroacetaldehyde hydrate |
| Molecular Formula: | C2H3Cl3O2 |
| SMILES: | OC(O)C(Cl)(Cl)Cl |
| Structure: |
|
| DrugBank Description: | A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication. |
| CAS Number: | 302-17-0 |
| Molecular Weight: | 165.403 |
| DrugBank Indication: | Mainly used as a hypnotic in the treatment of insomnia; however, it is only effective as a hypnotic for short-term use. May be used as a routine sedative preoperatively to decrease anxiety and cause sedation and/or sleep with respiration depression or cough reflex. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
